Elucidating the precise pharmacological system of action (MOA) of naturally developing compounds is often challenging. While Tarselli et al. (60) designed the first de novo artificial pathway to conolidine and showcased that this By natural means happening compound effectively suppresses responses to equally chemically induced and inflammation-deri